Luo, Y <br/><br/>
Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase.  [electronic resource] 

 -  Leukemia  Jun 2009 
 - 1171-4 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2008.401  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzamides<br/>Female<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myeloid, Chronic-Phase--mortality<br/>Male<br/>Middle Aged<br/>Piperazines--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Retrospective Studies<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Treatment Outcome<br/>Young Adult